{"url_path":"/sec/lfst/8-k/2026-06-04/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1845257/0001193125-26-257606-index.html","accession_number":"0001193125-26-257606","cik":"0001845257","ticker":"LFST","issuer_name":"LifeStance Health Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1845257/0001193125-26-257606-index.html","primary_entity_key":"0001845257","primary_entity_name":"LifeStance Health Group, Inc."},"word_count":260,"has_tables":true,"body_markdown":"Item 5.07\n\nSubmission of Matters to a Vote of Security Holders.\n\nOn June 2, 2026, LifeStance Health Group, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The following is a brief description of each proposal voted upon at the Annual Meeting and the final voting results for each such proposal.\n\nProposal 1: Election of Directors\n\nThe stockholders of the Company elected the director nominees listed below to serve on the Company’s Board of Directors as members of Class II for a term of three years. The results of the vote were as follows:\n\n \n\nName of Nominee\n  \nFor\n \n  \nWithhold\n \n  \nBroker Non-Votes\n \n\nDavid Bourdon\n\n  \n \n244,968,319\n \n  \n \n83,966,052\n \n  \n \n29,782,714\n \n\nRobert Bessler\n\n  \n \n280,015,618\n \n  \n \n48,918,753\n \n  \n \n29,782,714\n \n\nProposal 2: Ratification of the Company’s Independent Registered Public Accounting Firm\n\nThe stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2026. The results of the vote were as follows:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n357,756,707\n \n209,431\n \n750,947\n\nProposal 3: Advisory Vote on Named Executive Officer Compensation\n\nThe stockholders of the Company approved, on a non-binding advisory basis, the Company’s named executive officer compensation. The results of the vote were as follows:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n322,904,359\n \n5,675,861\n \n354,151\n \n29,782,714\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nLIFESTANCE HEALTH GROUP, INC.\n\nDate: June 4, 2026\n \n\n \nBy:\n \n\n/s/ Ryan Pardo\n\n \n\n \nName:\n \nRyan Pardo\n\n \n\n \nTitle:\n \nChief Legal Officer and Secretary"}